Trends, Collaborations and Technologies Revolutionizing Clinical trials.
Virtual - Zoom
Wednesday, March 29, 2023
12:00 PM - 1:00 PM
Add to Calendar
Eastern Standard Time
Join us as our panel discusses the changes in the clinical trials landscape. Our host Dr MaryAnne Rizk will lead the conversation with our guest speakers: Caroline Redeker, SVP, Corporate Development, Advanced Clinical; Nimita Limaye, Research VP, Life Sciences R&D Strategy and Technology IDC; Jessica Branning, CEO My Memory Clinic Site Network;
Kathrin Schoenborn-Sobolewski Start-up Advisor former Merck Group Executive
Trends: Through increased use of AI data, decentralization and digitalization, we can develop new treatments faster than ever before, with the confidence that they will safely and effectively treat the populations they are intended to help. Technology is modernizing the rapid pace to accelerate drug development and is shifting the paradigm, per the FDA, “Decentralized Clinical Trials (DCT) hold promise to reduce patient and sponsor burden and increase accrual and retention of a more diverse trial population”.
Technologies: Decentralization improves speed by accelerating enrollment (which can account for 60% of the total time of the trial and 80% of trial failures) and improves patient retention. By removing the barrier of geography, decentralization allows patients access to clinical research, regardless of how far they live from a clinic. By broadening the diversity of participants, we can produce data that is reflective of the population affected by the condition and improve scientific reliability.
Collaboration: With an estimate of 70% of life sciences using digital ecosystems, according to a 2022 IDC report, sponsors, CROs, sites and technology providers are collaborating in new ways to embrace innovation that yield demonstrated value for patients, sites and sponsors. Innovating with new data, decentralized and digitalization options creates new possibilities to accelerate effective therapies to patients faster, but who are the new ecosystem of collaborators to work with these new techniques.